Autism Acceptance Month, occurring in April, let us recommit ourselves to understand, support, and celebrate the diverse spectrum of human neurology.
The study “Epigenetic Alterations of Brain Non-Neuronal Cells in Major Mental Diseases,” unveils the critical role of non-neuronal brain cells in conditions like Autism Spectrum Disorder (ASD). Among others, HMGB1 protein has been identified for its significant role in the pathology of autism and neurological conditions.
Another study, focusing on “Maternal Separation Stress and Autistic-like Behaviors in Mice,” explores the impact of early-life stress on the development of ASD-like behaviors. This research identifies the neuroinflammatory response in the hippocampus as a potential mechanism driving these behaviors, triggered by maternal separation.
In the study is pointed out the HMGB1/TLR4 signaling cascade as a key player, offering new avenues for understanding and potentially mitigating the impacts of early-life stressors on ASD.
As we move from awareness to acceptance, we embrace the diversity and uniqueness of the autism community, with an inclusive approach to supporting individuals with ASD.
HMGBiotech continues to support this mission by providing crucial insights and tools for research in the field of neuroinflammation. Our work aims to illuminate the roles of biomarkers like HMGB1 in various conditions, fostering a deeper understanding and paving the way for innovative treatments.
Discover more and contact us for your pre-sales questions concerning HMGB1 protein
Read the full articles about the studies:
https://pubmed.ncbi.nlm.nih.gov/37107654
https://pubmed.ncbi.nlm.nih.gov/38110192/
